Tissue Regenix Group plc (AIM:TRX)
London · Delayed Price · Currency is GBP · Price in GBX 25.05
-0.45 (-1.76%)
Sep 9, 2025, 2:42 PM GMT+1
Tissue Regenix Group Market Cap
Tissue Regenix Group has a market cap or net worth of 18.16 million as of September 9, 2025. Its market cap has decreased by -60.47% in one year.
Market Cap
18.16M
Enterprise Value
24.42M
Revenue
22.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.05
Market Cap Chart
Since June 29, 2010, Tissue Regenix Group's market cap has decreased from 41.00M to 18.16M, a decrease of -55.70%. That is a compound annual growth rate of -5.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 18.16M | -57.50% |
| Dec 31, 2024 | 42.74M | 16.73% |
| Dec 29, 2023 | 36.61M | -7.68% |
| Dec 30, 2022 | 39.66M | 5.65% |
| Dec 31, 2021 | 37.54M | -0.93% |
| Dec 31, 2020 | 37.89M | 227.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |